LDP Pharma Study Group to Push Price Maintenance for Patented Meds, Rethink of “Off-Year” Re-Pricing towards Honebuto

May 20, 2022
A pharma study group of the ruling Liberal Democratic Party (LDP) on May 18 roughly approved its draft proposal for the government’s annual “ honebuto ” policy paper, which will call for the revisiting of “off-year” drug price revisions and...read more